Guilford, CT, United States of America

Harry Brielmann




Average Co-Inventor Count = 5.6

ph-index = 4

Forward Citations = 126(Granted Patents)


Company Filing History:


Years Active: 2002-2012

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Harry Brielmann: Innovator in Pharmaceutical Compounds

Introduction

Harry Brielmann, based in Guilford, CT, has made significant contributions to the field of pharmaceuticals through his innovative approach to developing compounds. With a total of nine patents to his name, Brielmann showcases a robust career as an inventor focused on creating solutions for health-related challenges.

Latest Patents

Among his latest innovations are the substituted biaryl piperazinyl-pyridine analogues. These compounds have been engineered to serve as ligands, demonstrating the capability to modulate specific receptor activities both in vivo and in vitro. The applications of these ligands are particularly promising, as they are designed for the treatment of conditions associated with pathological receptor activation in humans as well as domesticated and livestock animals. Furthermore, pharmaceutical compositions and methods derived from these compounds contribute to advancements in the treatment of various disorders, alongside methods for conducting receptor localization studies.

Career Highlights

Brielmann's professional journey includes tenure at Neurogen Corporation, where he honed his skills and contributed to groundbreaking research. His work has paved the way for future innovations in the pharmaceutical industry, evidencing his dedication to enhancing medical treatments.

Collaborations

Throughout his career, Harry has collaborated with notable coworkers, including Charles A. Blum and Xiaozhang Zheng. These partnerships have undoubtedly enriched his work, facilitating the exchange of ideas and fostering an environment conducive to innovation.

Conclusion

Harry Brielmann stands out as a noteworthy inventor in the pharmaceutical arena. With his impressive patent portfolio and collaborations, he continues to impact the field significantly. His ongoing work with substituted biaryl piperazinyl-pyridine analogues reflects a commitment to addressing critical health issues, ensuring his innovations remain at the forefront of medical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…